Track topics on Twitter Track topics that are important to you
Puma Biotechnology Inc. granted CANbridge Life Sciences Ltd. exclusive rights to develop and sell its breast cancer therapy N...
Original Article: CANbridge pays $30mm up front for rights to Puma's NerlynxNEXT ARTICLE
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...